Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta …

V Caso, JR de Groot, MS Fernandez, T Segura… - Heart, 2023 - heart.bmj.com
… To inform decision-makers whether the common practice of dosing outside of guidelines
produces optimal patient outcomes, it is necessary to systematically evaluate the clinical and …

Rivaroxaban precision dosing strategy for real‐world atrial fibrillation patients

R Konicki, D Weiner, J Herbert Patterson… - Clinical and …, 2020 - Wiley Online Library
… the optimal dose and regimen, the PK profiles and AUCs of several once-or-twice-daily dosing
regimens (with a total daily dosedoses for AF are given once daily, but twice-daily dosing

New avenues for optimal treatment of atrial fibrillation and stroke prevention

GM De Marchis, LA Sposato, M Kuehne, TD Dittrich… - Stroke, 2021 - Am Heart Assoc
… recommend dosing DOAC according to the label. Prescribing inappropriate low DOAC doses
… Moreover, strict DOAC adherence is paramount, as missing a DOAC dose can quickly lead …

Associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease

Y Xu, AR Chang, LA Inker, M McAdams-DeMarco… - Circulation, 2023 - Am Heart Assoc
… Therefore, optimal dosing in severe CKD is unclear owing to the lack of trial … optimal
apixaban dosing is thus of great clinical importance in this high-risk population. Apixaban dosing

How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing

XQ Liu, YW Yin, CY Wang, ZR Li, X Zhu… - Expert Review of …, 2021 - Taylor & Francis
… Therefore, when the rivaroxaban dose was delayed or missed, optimal remedial dosing
could help patients to restore the rivaroxaban concentration, FXa activity, or PT to the on-therapy …

Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation

S Tzeis, P Savvari, I Skiadas, S Patsilinakos… - Journal of Thrombosis …, 2021 - Springer
… monotherapy to inappropriately low doses of NOACs. However, inappropriate NOAC
dosing in the older AF patients still deprives them of optimal thromboprotection. Intensive …

… K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation  …

A Kotalczyk, Y Guo, Y Wang, GYH Lip… - … Journal of Stroke, 2022 - journals.sagepub.com
… Such practice is common in Asia, and we aimed to evaluate the use of low-dose NOACs
and their impact on clinical outcomes among Chinese patients with atrial fibrillation. …

[HTML][HTML] Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants

PP Bocchino, F Angelini, E Toso - Reviews in Cardiovascular …, 2021 - imrpress.com
optimal NOAC dosage as well as the preferred TAT and DAT duration following PCI in each
individual patient, as recommended by the latest ESC guidelines for AF [1, 50]. Nevertheless…

Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial

JG Best, L Arram, N Ahmed… - … Journal of Stroke, 2022 - journals.sagepub.com
Atrial fibrillation causes one-fifth of ischemic strokes, with a … for stroke prevention in atrial
fibrillation, initiation after stroke is … The dose may be reduced if recommended by the relevant …

Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide

A Capiau, T De Backer, M Grymonprez… - International Journal of …, 2021 - Elsevier
… of thromboembolism in non-valvular atrial fibrillation (NVAF) [1]… Selecting the preferable
DOAC in an appropriate dose can … ) have different doses and specific dose reduction criteria that …